Transforming high-content screening with intelligent imaging and AI analysis
June 26, 2025 at 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT
High-content imaging is essential in drug discovery, but as assays grow more complex, researchers need faster, more powerful imaging and analysis tools to extract high-quality data efficiently.
Register for this exclusive webinar to hear from two Molecular Devices experts, Dr. Angeline Lim and Dr. Andy Bashford, as they share real-world applications, including phenotypic profiling and patient-derived organoid imaging, using a next-generation high-content screening system - ImageXpress HCS.ai.
Discover how this platform can elevate your screening and image capturing with its enhanced imaging quality and AI-powered analysis, to improve assay reproducibility, produce deeper insights and take your screening to the next level.
Key learning objectives
- Master essential high-content imaging assays from 2D phenotypic profiling to 3D imaging using patient-derived organoids
- Discover the latest innovations in the ImageXpress HCS.ai platform and how it enhances speed, quality, and flexibility
- Explore the power of AI-driven analysis with IN Carta software to tackle the most challenging screening assays
Who should attend?
- Scientists, directors, managers and imaging specialists working in biotech, pharma and academic sectors.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Speakers
Dr. Angeline Lim is a Sr. Applications Scientist at Molecular Devices and has over 10 years of research experience. She gained her PhD in Molecular Cell and Developmental Biology from the University of California at Santa Cruz. Dr. Lim now specializes in automation, high-content imaging and analysis, and works predominately in developing automated 3D biology workflows by leveraging AI to derive actionable readouts from complex phenotypic assays. She provides scientific support for Molecular Devices' portfolio of ImageXpress High-Content Imaging Systems and its applications in high-throughput phenotypic profiling and 3D models in biology.
Dr. Andy Bashford is the Product Marketing Manager for Imaging at Molecular Devices. He completed his PhD at the University of Bath where he worked on transgenic models to study brain development and the biology of the primary cilium. Dr. Bashford has worked at Molecular Devices for 8 years with previous roles as Product Manager and Field Application Scientist, and has supported the launch of ImageXpress HCS.ai. He has also spent time working at the European Collection of Authenticated Cell Cultures (ECACC) where he developed assays, characterized and authenticated cell lines, and taught scientists good cell culture practice.
Moderator
